Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06800339 |
| Title | A Phase I, Single-Arm, Single-Institution Study Evaluating Neoadjuvant Chemoimmunotherapy with Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer (NEORADJUVANT) |
| Acronym | NEORADJUVANT |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | University of Maryland, Baltimore |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Maryland Proton Treatment Center | Baltimore | Maryland | 21201 | United States | Details | |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | United States | Details | |
| Upper Chesapeake- Kaufman Cancer Center | Bel Air | Maryland | 21014 | United States | Details | |
| Baltimore Washington Medical Center- Tate Cancer Center | Glen Burnie | Maryland | 21061 | United States | Details |